Improving pain control after cesarean section with nerve blocks
Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.
NA · University of Calgary · NCT06324942
This study is testing if a special pain relief method called TAP blocks can help women feel less pain and recover faster after having a cesarean section.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Calgary (other) |
| Locations | 1 site (Calgary, Alberta) |
| Trial ID | NCT06324942 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of Transversus Abdominis Plane (TAP) blocks administered by surgeons to enhance pain management for patients undergoing cesarean sections. The TAP block involves injecting a long-acting local anesthetic into the abdominal wall at the end of surgery, which may reduce the need for narcotics and promote quicker recovery. The study is randomized, comparing outcomes between patients receiving the TAP block and those who do not. The goal is to determine if this technique can lead to better postoperative pain control and shorter hospital stays.
Who should consider this trial
Good fit: Ideal candidates are patients undergoing elective cesarean sections under regional anesthesia with ASA status II to III.
Not a fit: Patients with known allergies to local anesthetics, those requiring general anesthesia, or those with chronic pain disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and recovery times for patients after cesarean sections.
How similar studies have performed: Previous studies on TAP blocks in other abdominal surgeries have shown promising results in reducing narcotic use and improving recovery, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA status II to III * All patients undergoing elective CS under regional anesthesia at any gestational age. Exclusion Criteria: * \- Known drug allergy to local anesthetics * Planned general anesthetic * NSAID use contraindicated post partum * Chronic pain disorder or chronic narcotic use/dependence * Planned vertical abdominal incision * Planned Cesarean Hysterectomy. * Placenta Previa or suspected Placenta Accreta
Where this trial is running
Calgary, Alberta
- University of Calgary — Calgary, Alberta, Canada (RECRUITING)
Study contacts
- Principal investigator: Stephen Wood, MD — University of Calgary
- Study coordinator: Stephen Wood, MD
- Email: slwood@ucalgary.ca
- Phone: 4039441438
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cesarean Section Complications, Pain, Postoperative